|[May 07, 2014]
Research and Markets: Myocardial Infarction Therapeutics Pipeline Review 2014 - Analysis of 55 Companies & 108 Drug Profiles
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/494gbf/myocardial)
has announced the addition of the "Myocardial
Infarction - Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutc
development for Myocardial Infarction, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Myocardial Infarction and special features on late-stage and
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
For more information visit http://www.researchandmarkets.com/research/494gbf/myocardial
[ Back To TMCnet.com's Homepage ]